A clinical trial funded by the National Institute of Health (NIH) revealed there is no significant difference in the effectiveness of furosemide and torsemide, two heart failure drugs, when it comes ...
The Horseracing Integrity and Safety Authority (HISA) has approved funding for three 18-month-long studies on the use of furosemide, also widely known as Lasix, on racehorses. Washington State ...
The US Food and Drug Administration (FDA) has approved a furosemide preparation (Furoscix, scPharmaceuticals) intended for subcutaneous self-administration by outpatients with chronic heart failure ...
LOUISVILLE, Ky. (WAVE) - 2020 marks the last time horses will be allowed to race in the Kentucky Derby while medicated with furosemide, the drug commonly known as Lasix. The medication prevents ...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, is introducing Furosemide for Injection, which is the generic of Lasix. Furosemide is indicated in ...
The Horseracing Integrity and Safety Authority released a request for proposals July 30 for research into whether furosemide, more commonly known as Lasix, is a performance-enhancing drug in ...
PHyoscine is antiemetic, sedative and radiographers some amnesia. Muscle relaxants are also controlled as neuromuscular blocking drugs. They are poorly as adjuncts to general anaesthesia, to toxic ...
The Kentucky Derby returns on the first Saturday in May after a pandemic-year running last September. Fans wearing fancy hats will be back in the stands. America’s most prestigious horse race, however ...
A paper published in the current edition of The Journal of the American Veterinary Medical Association calls for further study of an association between the use of Lasix in racehorses and sudden death ...
A Prescription Drug User Fee Act target date of July 26, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...
BARCELONA, Spain—Subcutaneous furosemide can help facilitate ambulatory early discharge of patients hospitalized for heart failure (HF), according to the randomized SUBCUT II HF trial. The strategy ...
A Prescription Drug User Fee Act target date of March 6, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results